265 related articles for article (PubMed ID: 33255651)
1. The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease.
Fragiadaki M; Macleod FM; Ong ACM
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255651
[TBL] [Abstract][Full Text] [Related]
2. Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).
Norman J
Biochim Biophys Acta; 2011 Oct; 1812(10):1327-36. PubMed ID: 21745567
[TBL] [Abstract][Full Text] [Related]
3. Polycystic Kidney Disease and Renal Fibrosis.
Xue C; Mei CL
Adv Exp Med Biol; 2019; 1165():81-100. PubMed ID: 31399962
[TBL] [Abstract][Full Text] [Related]
4. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
[TBL] [Abstract][Full Text] [Related]
5. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
[TBL] [Abstract][Full Text] [Related]
6. Recent Trends in ADPKD Research.
Shin YB; Park JH
Adv Exp Med Biol; 2016; 933():3-11. PubMed ID: 27730430
[TBL] [Abstract][Full Text] [Related]
7. No association of the TGF-beta1 gene polymorphisms with the renal progression in autosomal dominant polycystic kidney disease (ADPKD) patients.
Lee JG; Ahn C; Yoon SC; Park JH; Eo HS; No JJ; Kim KH; Lee EJ; Hwang YH; Hwang DY; Kim YS; Han JS; Kim S; Lee JS; Kim SH
Clin Nephrol; 2003 Jan; 59(1):10-6. PubMed ID: 12572925
[TBL] [Abstract][Full Text] [Related]
8. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis.
Lemoine H; Raud L; Foulquier F; Sayer JA; Lambert B; Olinger E; Lefèvre S; Knebelmann B; Harris PC; Trouvé P; Desprès A; Duneau G; Matignon M; Poyet A; Jourde-Chiche N; Guerrot D; Lemoine S; Seret G; Barroso-Gil M; Bingham C; Gilbert R; ; ; Le Meur Y; Audrézet MP; Cornec-Le Gall E
Am J Hum Genet; 2022 Aug; 109(8):1484-1499. PubMed ID: 35896117
[TBL] [Abstract][Full Text] [Related]
9. Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.
Lakhia R; Yheskel M; Flaten A; Ramalingam H; Aboudehen K; Ferrè S; Biggers L; Mishra A; Chaney C; Wallace DP; Carroll T; Igarashi P; Patel V
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32182218
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.
Xu N; Glockner JF; Rossetti S; Babovich-Vuksanovic D; Harris PC; Torres VE
J Nephrol; 2006; 19(4):529-34. PubMed ID: 17048214
[TBL] [Abstract][Full Text] [Related]
11. Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.
Patera F; Cudzich-Madry A; Huang Z; Fragiadaki M
Sci Rep; 2019 Mar; 9(1):4491. PubMed ID: 30872773
[TBL] [Abstract][Full Text] [Related]
12. Genome-Scale Single Nucleotide Resolution Analysis of DNA Methylation in Human Autosomal Dominant Polycystic Kidney Disease.
Bowden SA; Rodger EJ; Bates M; Chatterjee A; Eccles MR; Stayner C
Am J Nephrol; 2018; 48(6):415-424. PubMed ID: 30463078
[TBL] [Abstract][Full Text] [Related]
13. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
Sessa A; Ghiggeri GM; Turco AE
J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
[TBL] [Abstract][Full Text] [Related]
15. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation.
Lee EJ; Park EY; Mun H; Chang E; Ko JY; Kim DY; Park JH
FASEB J; 2015 Aug; 29(8):3506-14. PubMed ID: 25934702
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of extracellular matrix glycoproteins undulin and tenascin in human autosomal dominant polycystic kidney disease.
Klingel R; Ramadori G; Schuppan D; Knittel T; Meyer zum Büschenfelde KH; Köhler H
Nephron; 1993; 65(1):111-8. PubMed ID: 7692313
[TBL] [Abstract][Full Text] [Related]
17. Lessons from microRNA biology: Top key cellular drivers of Autosomal Dominant Polycystic Kidney Disease.
Fragiadaki M
Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166358. PubMed ID: 35150832
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
Elberg D; Jayaraman S; Turman MA; Elberg G
Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
[TBL] [Abstract][Full Text] [Related]
19. Profiling conserved biological pathways in Autosomal Dominant Polycystic Kidney Disorder (ADPKD) to elucidate key transcriptomic alterations regulating cystogenesis: A cross-species meta-analysis approach.
Chatterjee S; Verma SP; Pandey P
Gene; 2017 Sep; 627():434-450. PubMed ID: 28676447
[TBL] [Abstract][Full Text] [Related]
20. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
